NCT00230958View on ClinicalTrials.gov

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Chronic Hepatitis C
Interventions
DRUG

Viramidine

DRUG

Ribavirin

DRUG

pegylated interferon alfa-2b

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00230958 - Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive | Biotech Hunter | Biotech Hunter